Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Raffaella Palumbo,1 Federico Sottotetti,1 Giuseppe Trifirò,2 Elena Piazza,3 Antonella Ferzi,4 Anna Gambaro,3 Elena Giulia Spinapolice,2 Emma Pozzi,1 Barbara Tagliaferri,1 Cristina Teragni,1 Antonio Bernardo1 1Departmental Unit of Oncology, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy...

Full description

Bibliographic Details
Main Authors: Palumbo R, Sottotetti F, Trifirò G, Piazza E, Ferzi A, Gambaro A, Spinapolice EG, Pozzi E, Tagliaferri B, Teragni C, Bernardo A
Format: Article
Language:English
Published: Dove Medical Press 2015-04-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/nanoparticle-albumin-bound-paclitaxel-nab-paclitaxel-as-second-line-ch-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/nanoparticle-albumin-bound-paclitaxel-nab-paclitaxel-as-second-line-ch-peer-reviewed-article-DDDT

Similar Items